Nautilus Biotechnology to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference – GlobeNewswire

Posted: May 27, 2024 at 2:47 am

SEATTLE, May 23, 2024 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or Nautilus), a company pioneering a single-molecule protein analysis platform, today announced the company will be participating in the Goldman Sachs 45th Annual Healthcare Conference.

Nautilus management is scheduled to participate in a fireside chat on Monday, June 10, 2024, at 8:40 a.m. Eastern Time. Interested parties may access a live and archived webcast of the presentation on the Investors section of the company website at: http://www.nautilus.bio.

About Nautilus Biotechnology, Inc. With its corporate headquarters in Seattle, Washington and its research and development headquarters in San Carlos, California, Nautilus is a development stage life sciences company working to create a platform technology for quantifying and unlocking the complexity of the proteome. Nautilus mission is to transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. To learn more about Nautilus, visit http://www.nautilus.bio.

Media Contact press@nautilus.bio

Investor Contact investorrelations@nautilus.bio

See more here:
Nautilus Biotechnology to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference - GlobeNewswire

Related Posts